Equels Thomas K bought AIM
March 15, 2024 · Form 4 insider transaction
Equels Thomas K bought 75,758 shares of AIM ImmunoTech Inc. at $0.33 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,758
Price
$0.33
Total value
$25.0K
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 15, 2024
Filing dateMarch 18, 2024
Shares owned after716,455
OwnershipDirect
10b5-1 planNo
AmendedNo